In addition, multiple clinical studies of BTZ have reported increased rates of certain toxicities, notably peripheral neuropathy, gastrointestinal issues, thrombocytopenia, and herpes zoster reactivation (49, 50). This evidence concerns the gene CASC3 and peripheral neuropathy.